Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News

9/29/10Follow @xconomy

The past week has kept us buzzing with news of funding rounds for startups in the cleantech, biotech, software, and Internet spaces.

—Cambridge, MA-based Ironwood Pharmaceuticals (NASDAQ: IRWD) sold its biomanufacturing unit, Mircrobia, to Dutch chemical giant Royal DSM. The purchaser did not reveal how much it paid for Lexington, MA-based Microbia, which designs microbes used to make chemicals from renewable sources and is said to have brought $1 million in losses to Ironwood in 2009.

—Cambridge-based Vertex Pharmaceuticals announced its plans to offer $375 million worth of convertible senior subordinated notes, due in 2015 in a public offering. Vertex (NASDAQ: VRTX) underwriter BofA Merrill Lynch also received the option to purchase up to $25 million in additional notes as part of the terms of the offering.

—Mocospace, a Boston-based mobile social networking and entertainment startup, announced it had received a $3.5 million investment from SoftBank Capital. The company will use the money for adding to its management team and expanding its offerings of Web-based social games for mobile phones. SoftBank joins existing Mocospace investors General Catalyst, Pilot Group, and angel backer Michael Dearing.

Dana Farber Cancer Institute of Boston received $33 million from French drug giant Sanofi-Aventis to license technology for identifying cancer targets for new treatments. The Boston organization will also receive at least three years of research funding from Sanofi, in addition to possible payments tied to drugs developed as part of the agreement.

— Burlington, MA-based Aspen Technology (NASDAQ: AZPN), a maker of software for manufacturing optimization, priced a secondary public offering of 18 million shares at $9 per share, an increase from its originally expected offering of 15 million shares.

—Burlington-based medical device startup Rhythmia Medical raised $5 million of a possible $7 million equity-based financing, bringing the company’s total funding pot to $17 million.

—Harvest Automation, a Billerica, MA-based robotics company working on automating the harvesting of commercial plants, topped off its Series A round at $5.3 million, with a $1.3 million investment from Cambridge- and New York City-based Founder Collective. The startup brought in the first $4 million of the funding round in January of this year.

—Cambridge-based DecImmune Therapeutics, a developer of drugs for treating tissue damage, said it had raised $1 million in equity-based funding from Astellas Venture Management, the venture capital arm of Japanese drugmaker Astellas Pharma. The startup, formerly known as Natural Antibodies, also said it received $2.2 million in research grant money from the National Institutes of Health.

OnePIN, a Westborough, MA-based maker of mobile phone software for managing social contacts, raised $1.9 million of a potential $3.1 million equity-based funding round, an SEC filing showed. The company has previously received funding from FA Technology Ventures, Greycroft Partners, Egan-Managed Capital, and Stage 1 Technology Ventures.

—Marlborough, MA-based diagnostics company PointCare Technologies pulled in $1.8 million of an equity offering that could total $3.5 million, according to an SEC filing. The startup produces lower-cost, multi-purpose devices for targeting HIV/AIDS in developing countries.

—Andera, a Providence, RI-based maker of Web-based software for banks and other institutions offering online account opening and funding to consumers, said it had wrapped up a $9 million financing, led by Edison Venture Fund. The money will go to expanding Andera’s sales, marketing, and product development efforts.

—An SEC filing showed that Mechanology, an Attleboro, MA-based developer of compressor technology, raised $5.8 million in an equity round that could total $6.5 million.

By posting a comment, you agree to our terms and conditions.